Skip to content
healthcare.dev

Sitagliptin

NDC 70710-1901, Sitagliptin, tablet, from Zydus Pharmaceuticals (USA) Inc..

Product NDC
70710-1901
Status
Listed
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA211566
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1901 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN100 mg/1

Pharmacologic classes

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
70710-1901-37071019010330 TABLET in 1 BOTTLE (70710-1901-3)
70710-1901-97071019010990 TABLET in 1 BOTTLE (70710-1901-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6a970e80-b753-48fa-9fff-87e7a5044982

Use it

Look up 70710-1901 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1901 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.